NAD + - and EVA1-C-dependent reversal of neurological deficits is mediated by differential alternative RNA splicing in tauopathic animal models
Authors:
- Ruixue AiRuixue Ai
- Lipeng MaoLMLipeng Mao
- Xurui JinXJXurui Jin
- Shi-Qi ZhangSZShi-Qi Zhang
- Junping PanJPJunping Pan
- Maria Jose Donate LagartosMLMaria Jose Donate Lagartos
- Shu-Qin CaoSCShu-Qin Cao
- Guang YangGuang Yang
- Chenglong XieCXChenglong Xie
- Xiongbin KangXKXiongbin Kang
- Pingjie WangPWPingjie Wang
- Yang HuYHYang Hu
Preprint
Abstract
Aberrant alternative splicing (ASEs) is an aging hallmark to Alzheimer’s Disease (AD). Although NAD + and related metabolites can slow down AD, NAD + on ASEs in AD remain unclear. Mouse transcriptomic data revealed NR-induced ASEs, focusing on the Eva1-C locus. AI-based algorithms predicted EVA1-C protein structures and protein-protein interactions. AD postmortem brain samples and tauopathy models including transgenic mice and worm was used for validation. NAD + abundance/metabolic status modulates ASEs and the expression of EVA1-C isoforms, which in turn regulate the interaction with BAG-1 and HSP70 proteins. Importantly, EVA1-C is dramatically reduced in 20 Braak 5/6 AD patients compared to cognitive normal humans in different brain regions. NAD + metabolism modulates abundance of specific mRNA isoforms, and that ASEs influence disease progression in model tauopathies and potentially AD. These results could facilitate future development of NAD + -based splice-switching therapeutics for AD. Teaser: Unveiling the Link Between NAD + Metabolism and Alzheimer’s Disease: Discovering the Role of Alternative RNA Splicing in Disease Progression and Potential Therapeutic TargetsKeywords
This publication has 115 references indexed in Scilit:
- Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia TelangiectasiaMovement Disorders, 2021
- Re-emphasizing early Alzheimer’s disease pathology starting in select entorhinal neurons, with a special focus on mitophagyAgeing Research Reviews, 2021
- Alternative splicing in Alzheimer’s diseaseAging Clinical and Experimental Research, 2019
- Alternative splicing in a presenilin 2 variant associated with Alzheimer diseaseAnnals of Clinical and Translational Neurology, 2019
- Axon guidance pathways and the control of gene expressionDevelopmental Dynamics, 2017
- The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer’s diseaseHistochemistry and Cell Biology, 2015
- Differential expression of RARβ isoforms in the mouse striatum during development: A gradient of RARβ2 expression along the rostrocaudal axisDevelopmental Dynamics, 2005
- Scoring function for automated assessment of protein structure template qualityProteins: Structure, Function, and Bioinformatics, 2004
- Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursorBiochemical and Biophysical Research Communications, 1992
- Human Neutrophil Granule Cationic Protein CAP37 is a Specific Macrophage Chemotaxin that Shares Homology with Inflammatory Proteinases1991